Irish Medical Equipment Stock News

Glenveagh Properties (ISE:GVR) FY 2025 Earnings Snapshot Glenveagh Properties (ISE:GVR) has opened FY 2025 with first half revenue of €341.6 million and EPS of €0.052, setting the tone against a trailing twelve month backdrop of €1.06 billion in revenue and EPS of €0.220. The company has seen revenue move from €152.2 million and EPS of €0.0012 in the first half of 2024 to €717.0 million and EPS of €0.1632 in the second half of 2024, before reaching the current run rate reflected in the latest...

Ryanair Holdings stock after recent performance Ryanair Holdings (ISE:RYA) has drawn fresh attention after recent share performance, with the stock showing a 13.6% decline over the past 3 months and a 13.8% decline year to date. See our latest analysis for Ryanair Holdings. At a share price of €25.61, Ryanair’s recent 30 day share price return of 3.43% decline and 90 day share price return of 13.63% decline suggest fading short term momentum. However, the 1 year total shareholder return of...

If you are wondering whether Ryanair Holdings is still good value after its recent run, this article walks through what the current share price could mean for you. The stock recently closed at €26.61, with returns of 31.1% over 1 year and 96.1% over 3 years. The share price has seen shorter term moves including a 1.4% decline over 7 days and a 5.6% decline over 30 days, with a year-to-date decline of 10.4%. Recent news coverage has focused on Ryanair's position in European low-cost air...

Bank of Ireland Group (ISE:BIRG) has drawn fresh attention after announcing a proposed 2025 final dividend of €0.45 per share and a €530 million share buyback, released alongside its latest full year earnings report. See our latest analysis for Bank of Ireland Group. At a share price of €15.235, Bank of Ireland Group has seen a 1-year total shareholder return of 32.36%, while the 30-day share price return of 10.33% and year-to-date share price return of 8.83% suggest some recent momentum has...

Earnings, dividend and buyback: what changed at Glanbia (ISE:GL9) Glanbia (ISE:GL9) has drawn fresh attention after reporting full year earnings, recommending a higher annual dividend and launching a share buyback program of up to €100 million. See our latest analysis for Glanbia. The market reaction has been broadly positive, with a 90 day share price return of 16.87% and a year to date share price return of 19.61%. The 1 year total shareholder return of 76.82% points to strong momentum...

Earnings and dividend announcement put Uniphar in focus Uniphar (ISE:UPR) has drawn attention after releasing its full year 2025 results, showing €3,074.7 million in sales and €51.09 million in net income, alongside a proposed final dividend of €0.0131 per share. The board’s proposal brings the total dividend for 2025 to €0.0202 per ordinary share, combining the final payout with the previously declared interim dividend of €0.0071 per share. See our latest analysis for Uniphar. Uniphar’s...

Glanbia (ISE:GL9) has reported its FY 2025 results with second half revenue of US$2.0 billion and basic EPS of US$0.34, alongside net income of US$83.9 million, putting fresh numbers behind the current share price of €17.25. The company has seen half year revenue move from US$2.02 billion with EPS of US$0.08 in 2024 H2 to US$1.93 billion and US$0.39 in 2025 H1, before landing at US$2.0 billion and US$0.34 in 2025 H2. This sets up a picture where margin trends and earnings quality are front of...

Why Kingspan Group’s latest earnings are on investors’ radar Kingspan Group (ISE:KRX) has attracted fresh attention after reporting full year 2025 earnings, with sales of €9,199 million and net income of €671.2 million, alongside progress in emissions reduction and US roofing expansion. See our latest analysis for Kingspan Group. The earnings release appears to have reset expectations, with the 1-day share price return of 7.72% lifting Kingspan to €85.8. A 30-day share price return of 18.92%...

Why Kerry Group (ISE:KRZ) Is On Investors’ Radar Today Kerry Group (ISE:KRZ) has caught investors’ attention after a period of weak share price performance, with the stock showing negative returns over the past year and past 3 months. Against that backdrop, some investors are revisiting the company’s current valuation and business profile, including its taste and nutrition solutions portfolio and recent annual revenue and net income figures. See our latest analysis for Kerry Group. With the...

Those following along with Kerry Group plc ( ISE:KRZ ) will no doubt be intrigued by the recent purchase of shares by...

Kingspan Group plc ( ISE:KRX ) led the ISE gainers with a relatively large price hike in the past couple of weeks. The...

For many, the main point of investing in the stock market is to achieve spectacular returns. And we've seen some truly...

If you are wondering whether Glanbia’s current share price offers good value, it helps to look at how that price lines up with the fundamentals rather than just the headline moves. The stock most recently closed at €16.62, with returns of 1.8% over 7 days, 14.0% over 30 days, 14.8% year to date, 21.0% over 1 year, 60.5% over 3 years and 89.7% over 5 years. This may shape how you think about both upside and risk. Recent coverage around Glanbia has focused on its position within the food,...

Key Insights Significant control over Glanbia by retail investors implies that the general public has more power to...

The main point of investing for the long term is to make money. Better yet, you'd like to see the share price move up...

Uniphar plc ( ISE:UPR ), is not the largest company out there, but it received a lot of attention from a substantial...

Key Insights The projected fair value for Kerry Group is €140 based on 2 Stage Free Cash Flow to Equity Kerry Group is...

Glenveagh Properties (ISE:GVR) has put two clear signals on the table: a new share buyback of up to €25 million and guidance to scale homebuilding output to about 2,000 units by 2027. See our latest analysis for Glenveagh Properties. Those capital return and growth plans come after a solid stretch of gains, with the share price at €2.01 and a 90 day share price return of 10.93%. The 1 year total shareholder return sits at 30.52% and the 5 year total shareholder return is 136.47%, suggesting...

Quite a few insiders have dramatically grown their holdings in Glanbia plc ( ISE:GL9 ) over the past 12 months. An...

Kingspan Group (ISE:KRX) has had a rough month with its share price down 4.2%. However, a closer look at its sound...

Some investors rely on dividends for growing their wealth, and if you're one of those dividend sleuths, you might be...

As the pan-European STOXX Europe 600 Index reaches new heights, buoyed by an improving economic backdrop and marking its strongest yearly performance since 2021, investors are increasingly focusing on small-cap opportunities within this dynamic market landscape. In such a thriving environment, identifying stocks with strong fundamentals and insider activity can highlight potential undervalued opportunities in the European small-cap sector.

Ryanair Holdings plc ( ISE:RYA ) is reducing its dividend from last year's comparable payment to €0.193 on the 25th of...

Zevra Therapeutics announced that it has entered into an exclusive expanded access distribution agreement with Ireland-based Uniphar, enabling Niemann-Pick Disease Type C patients in select territories outside Europe to obtain reimbursed named-patient supply of MIPLYFFA, the only approved therapy that targets the underlying pathology of this ultra-rare condition. The deal strengthens Uniphar’s position as a specialist partner for complex rare-disease logistics, highlighting its capabilities...